Binding of β-carbolines and related agents at serotonin (5-HT2 and 5- HT(1A)), dopamine (D2) and benzodiazepine receptors

Drug and Alcohol Dependence

Volumn 60, Issue 2, 2000, Pages 121-132

  Glennon, Richard A ^a   Dukat, Malgorzata ^a   Grella, Brian ^a   Hong, Seoung Soo ^a   Costantino, Luca ^a   Teitler, Milt ^b   Smith, Carol ^b   Egan, Chris ^b   Davis, Katherine ^b   Mattson, Mariena V ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

carbolines; 1 (2,5 Dimethoxy 4 methylphenyl) 2 aminopropane (DOM); Benzodiazepine receptors; Dimethyltryptamine (DMT); Dopamine receptors; Hallucinogens; Harmaline; Harmine; PI hydrolysis; Serotonin receptors

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; ANILINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; BETA CARBOLINE DERIVATIVE; DOPAMINE 2 RECEPTOR; INDOLEAMINE; INOSITOL PHOSPHATE; PSYCHEDELIC AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG RECEPTOR BINDING; MALE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; CARBOLINES; CELL LINE; HYDROLYSIS; INOSITOL PHOSPHATES; N,N-DIMETHYLTRYPTAMINE; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1;

EID: 0034254956     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00148-9     Document Type: Article

References (35)

1. Allen M.S., LaLoggia A.J., Dorn L.J., Martin M.J., Costantino G., Hagen T.J., Koehler K.F., Skolnick P., Cook J.M. Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach. J. Med. Chem. 35:1992;4001-4010.
2. A receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J. Neurochem. 53:1989;1057-1063.
3. 2 serotonin receptors. J. Neurochem. 43:1984;1213-1219.
4. 2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-β-carbolines. Pharmazie. 48:1993;289-294.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
6. A receptors. J. Med. Chem. 41:1998;2537-2552.
7. 2 receptors. Biochem. Pharmacol. 41:1991;1739-1744.
8. Deulofeu V. Chemical compounds isolated from Banesteriopsis and related species. Efron D.K., Holmstedt B., Kline N.S. Ethnopharmacologic Search for Psychoactive Drugs. 1967;393-402 US Government Printing Office, Washington, DC.
9. 2C receptors. Psychopharmacology. 136:1998;409-414.
10. 2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro. Life Sci. 63:1998;215-222.
11. Glennon R.A. Serotonin receptor interactions of harmaline and several related β-carbolines. Life Sci. 29:1981;861-866.
12. Glennon R.A. Classical hallucinogens. Schuster C.R., Kuhar M.J. Pharmacological Aspects of Drug Dependence. 1996;343-371 Springer, Berlin.
13. Glennon R.A. Pharmacology of hallucinogens. Tarter R.E., Ammerman R.T., Ott P.J. Handbook of Substance Abuse - Neurobehavioral Pharmacology. 1998;217-227 Plenum, New York.
14. Glennon R.A., Young R., Jacyno J.M., Slusher M., Rosecrans J.A. DOM-Stimulus generalization to LSD and other hallucinogenic indolealkylamines. Eur. J. Pharmacol. 86:1983;453-459.
15. Grella B., Dukat M., Young R., Teitler M., Herrick-Davis K., Gauthier C.B., Glennon R.A. Investigation of hallucinogenic and related β-carbolines. Drug. Alcohol Depend. 50:1998;99-107.
16. Grob C.S., McKenna D.J., Callaway J.C., Brito G.S., Neves E.S., Oberlaender G., Saide O.L., Labigalini E., Tacla C., Miranda C.T., Strassman R.J., Boone K.B. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J. Nerv. Mental Dis. 184:1996;86-94.
17. 2A component of the ibogaine-induced discriminative stimulus. Pharmacol. Biochem. Behav. 59:1998;419-425.
18. Helsley S., Rabin R.A., Winter J.C. The effects of β-carbolines in rats trained with ibogaine as a discriminative stimulus. Eur. J. Pharmacol. 345:1998;139-143.
19. 2C receptor. J. Neurochem. 69:1997;1138-1144.
20. Hollinshead S.P., Trudell M.L., Skolnick P., Cook J.M. Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester. J. Med. Chem. 33:1990;1062-1069.
21. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
22. Ishida A., Nakamura T., Iric K., Oh-ishi T. A new method for the preparation of 3,4-dihydro- and 1,2,3,4-tetrahydro-β-carbolines. Chem. Pharm. Bull. 33:1985;3237-3249.
23. McKenna D.J., Repke D.B., Peroutka S.J. Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology. 29:1990;193-198.
24. 2A serotonin receptor binding. J. Med. Chem. 41:1998;5084-5093.
25. Naranjo C. Psychotropic properties of the harmala alkaloids. Efron D.K., Holmstedt B., Kline N.S. Ethnopharmacologic Search for Psychoactive Drugs. 1967;385-391 US Government Printing Office, Washington, DC.
26. Naranjo C. Psychotherapeutic possibilities of new fantasy-enhancing drugs. Clin.Toxicol. 2:1969;209-224.
27. Naranjo C. The Healing Journey. 1973;Pantheon Books, New York.
28. 2C receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;1-6.
29. Pennes H.H., Hoch P.H. Psychotomimetics, clinical and theoretical considerations: Harmine, WIN-2299 and nalline. Am. J. Psychiat. 113:1957;887-892.
30. Rivier L., Lindgren J.-E. 'Ayahuasca', the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ. Bot. 26:1972;101-129.
31. Schultes R.E. The place of ethnobotany in the ethnopharmacologic search for psychotomimetic drugs. Efron D.K., Holmstedt B., Kline N.S. Ethnopharmacologic Search for Psychoactive Drugs. 1967;33-57 US Government Printing Office, Washington, DC.
32. Shulgin A., Shulgin A. Tihkal. 1997;Transform Press, Berkeley, CA.
33. Shulgin A., Shulgin A. Pihkal. 1991;Transform Press, Berkeley, CA.
34. Strassman R.J. Adverse reactions to psychedelic drugs. A review of the literature. J. Nerv. Ment. Dis. 172:1984;577-595.
35. Yamada F., Saida Y., Somei M. Structural determination of a natural alkaloid, 5-methoxy-1-oxo-1,2,3,4-tetrahydro-β-carboline and the synthesis of the corresponding 8-methoxy compound. Heterocycles. 24:1986;2619-2627.